Home The Word Brain My Amedeo FAQ Privacy About   


2049 Chinese

The 20K Word Road to Mandarin Proficiency

By B. S. Kamps et al.


  Influenza

  Free Subscription


05.02.2024

1 Am J Med
6 BMJ
2 Drug Saf
2 J Gen Virol
2 J Virol
1 MMWR Morb Mortal Wkly Rep
5 Pediatrics
1 PLoS Biol
1 PLoS Comput Biol
19 PLoS One
1 Vaccine
3 Virology


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Med

  1. WOOD SK, Maki DG, Glickman M, Hennekens CH, et al
    Guidance for Health Care Providers on the Newest COVID-19 Vaccine.
    Am J Med. 2024;137:79-80.
    PubMed        


    BMJ

  2. BOYTCHEV H
    RSV vaccines administered in error to infants and pregnant people, CDC reports.
    BMJ. 2024;384:q236.
    PubMed        

  3. MICHAELS D, Spieler EA, Wagner GR
    US workers during the covid-19 pandemic: uneven risks, inadequate protections, and predictable consequences.
    BMJ. 2024;384:e076623.
    PubMed        

  4. IACOBUCCI G
    Government wrote off almost pound10bn worth of unused PPE during pandemic, accounts show.
    BMJ. 2024;384:q227.
    PubMed        

  5. WISE J
    Covid inquiry: What did we learn this week?
    BMJ. 2024;384:q229.
    PubMed        

  6. WATERS A
    Covid-19: Doctors instruct law firm in bid for compensation after developing long covid.
    BMJ. 2024;384:q188.
    PubMed        

  7. BRINDLEY P
    Essential workers during covid-19: how quickly we forget.
    BMJ. 2024;384:q179.
    PubMed        


    Drug Saf

  8. QIN SX, Cheng FWT, Kwok WC, Fung LWY, et al
    Effectiveness and Respiratory Adverse Events Following Inactivated and mRNA COVID-19 Vaccines in Patients with COPD and Asthma: A Chinese Population-Based Study.
    Drug Saf. 2024;47:135-146.
    PubMed         Abstract available

  9. DONG G, Bate A, Haguinet F, Westman G, et al
    Optimizing Signal Management in a Vaccine Adverse Event Reporting System: A Proof-of-Concept with COVID-19 Vaccines Using Signs, Symptoms, and Natural Language Processing.
    Drug Saf. 2024;47:173-182.
    PubMed         Abstract available


    J Gen Virol

  10. MCMILLAN CLD, Wijesundara DK, Choo JJY, Amarilla AA, et al
    Enhancement of cellular immunity following needle-free vaccination of mice with SARS-CoV-2 spike protein.
    J Gen Virol. 2024;105.
    PubMed         Abstract available

  11. SEEKINGS AH, Liang Y, Warren CJ, Hjulsager CK, et al
    Transmission dynamics and pathogenesis differ between pheasants and partridges infected with clade 2.3.4.4b H5N8 and H5N1 high-pathogenicity avian influenza viruses.
    J Gen Virol. 2024;105.
    PubMed         Abstract available


    J Virol

  12. LI H, Sun H, Tao M, Han Q, et al
    Recombinant parainfluenza virus 5 expressing clade 2.3.4.4b H5 hemagglutinin protein confers broad protection against H5Ny influenza viruses.
    J Virol. 2024 Feb 2:e0112923. doi: 10.1128/jvi.01129.
    PubMed         Abstract available

  13. ROWE T, Davis W, Wentworth DE, Ross T, et al
    Differential interferon responses to influenza A and B viruses in primary ferret respiratory epithelial cells.
    J Virol. 2024 Jan 31:e0149423. doi: 10.1128/jvi.01494.
    PubMed         Abstract available


    MMWR Morb Mortal Wkly Rep

  14. MONACH PA, Anand ST, Fillmore NR, La J, et al
    Underuse of Antiviral Drugs to Prevent Progression to Severe COVID-19 - Veterans Health Administration, March-September 2022.
    MMWR Morb Mortal Wkly Rep. 2024;73:57-61.
    PubMed         Abstract available


    Pediatrics

  15. BURSTEIN B, Florin TA, Sabhaney V, Xie J, et al
    Inflammatory Markers in Febrile Young Infants With and Without SARS-CoV-2 Infections.
    Pediatrics. 2024 Jan 3:e2023063857. doi: 10.1542/peds.2023-063857.
    PubMed        

  16. POUKKA E, Andersson NW, Thiesson EM, Baum U, et al
    COVID-19 Vaccine Effectiveness Among Adolescents.
    Pediatrics. 2024 Jan 10:e2023062520. doi: 10.1542/peds.2023-062520.
    PubMed         Abstract available

  17. DAY-LEWIS M, Berbert L, Baker A, Dionne A, et al
    Updated Case Definition of MIS-C and Implications for Clinical Care.
    Pediatrics. 2024;153:e2023063259.
    PubMed         Abstract available

  18. DIAS CS, Diniz LM, Oliveira MCL, Simoes E Silva AC, et al
    Outcomes of SARS-CoV-2 and Seasonal Viruses Among Children Hospitalized in Brazil.
    Pediatrics. 2024;153:e2023064326.
    PubMed         Abstract available

  19. WALKER GJ, Foster CSP, Sevendal A, Domazetovska A, et al
    Clinical, Genomic, and Immunological Characterization of RSV Surge in Sydney, Australia, 2022.
    Pediatrics. 2024;153:e2023063667.
    PubMed         Abstract available


    PLoS Biol

  20. RUSSELL TW, Townsley H, Abbott S, Hellewell J, et al
    Combined analyses of within-host SARS-CoV-2 viral kinetics and information on past exposures to the virus in a human cohort identifies intrinsic differences of Omicron and Delta variants.
    PLoS Biol. 2024;22:e3002463.
    PubMed         Abstract available


    PLoS Comput Biol

  21. RAMACHANDRAN A, Lumetta SS, Chen D
    PandoGen: Generating complete instances of future SARS-CoV-2 sequences using Deep Learning.
    PLoS Comput Biol. 2024;20:e1011790.
    PubMed         Abstract available


    PLoS One

  22. AVILA-HERRERA A, Kimbrel JA, Manuel Marti J, Thissen J, et al
    Differential laboratory passaging of SARS-CoV-2 viral stocks impacts the in vitro assessment of neutralizing antibodies.
    PLoS One. 2024;19:e0289198.
    PubMed         Abstract available

  23. JABRAEILIAN H, Jamali Y
    Omicron vs. the rest: Assessing the competitive dynamics and coinfection scenarios of COVID-19 strains on a social network.
    PLoS One. 2024;19:e0287623.
    PubMed         Abstract available

  24. KALIBATAS V, Kalibatiene L, Imashpayev D
    Blood donations and donors' profile in Lithuania: Trends for coming back after the COVID-19 outbreak.
    PLoS One. 2024;19:e0297580.
    PubMed         Abstract available

  25. NEHME A, Moussa S, Fekih-Romdhane F, Yakin E, et al
    Expressive suppression moderates the relationship between PTSD from COVID-19 and somatization and validation of the Arabic version of Patient Health Questionnaire-15 (PHQ-15).
    PLoS One. 2024;19:e0293081.
    PubMed         Abstract available

  26. TREGNAGO D, Avancini A, Belluomini L, Trestini I, et al
    Cross-sectional survey evaluating the psychological impact of the COVID-19 vaccination campaign in patients with cancer: The VACCINATE study.
    PLoS One. 2024;19:e0290792.
    PubMed         Abstract available

  27. PARK H, Choi CM, Kim SH, Kim SH, et al
    In-hospital real-time prediction of COVID-19 severity regardless of disease phase using electronic health records.
    PLoS One. 2024;19:e0294362.
    PubMed         Abstract available

  28. CERDA A, Rivera M, Armijo G, Ibarra-Henriquez C, et al
    An Open One-Step RT-qPCR for SARS-CoV-2 detection.
    PLoS One. 2024;19:e0297081.
    PubMed         Abstract available

  29. MOXLEY TA, Johnson-Leung J, Seamon E, Williams C, et al
    Application of elastic net regression for modeling COVID-19 sociodemographic risk factors.
    PLoS One. 2024;19:e0297065.
    PubMed         Abstract available

  30. OBEIDAT M, Abu Zahra A, Alsattari F
    Prevalence and characteristics of long COVID-19 in Jordan: A cross sectional survey.
    PLoS One. 2024;19:e0295969.
    PubMed         Abstract available

  31. ANASTASAKIS DG, Benhalevy D, Cuburu N, Altan-Bonnet N, et al
    Epigenetic repression of antiviral genes by SARS-CoV-2 NSP1.
    PLoS One. 2024;19:e0297262.
    PubMed         Abstract available

  32. SHIDA H, Komamine M, Kajiyama K, Waki T, et al
    Real-world prescription of anti-COVID-19 drugs in hospitalized patients with COVID-19 in Japan.
    PLoS One. 2024;19:e0297679.
    PubMed         Abstract available

  33. NKYI AK, Baaba B
    Coping, health anxiety, and stress among health professionals during Covid-19, Cape Coast, Ghana.
    PLoS One. 2024;19:e0296720.
    PubMed         Abstract available

  34. GEHRING S, Kowalzik F, Okasha O, Engelmann T, et al
    A prospective cohort study of SARS-CoV-2 infection-induced seroconversion and disease incidence in German healthcare workers before and during the rollout of COVID-19 vaccines.
    PLoS One. 2024;19:e0294025.
    PubMed         Abstract available

  35. XIANG W, Wang Z, Pan X, Liu X, et al
    The balance between traffic control and economic development in tourist cities under the context of COVID-19: A case study of Xi'an, China.
    PLoS One. 2024;19:e0295950.
    PubMed         Abstract available

  36. RAO JS, Liu T, Diaz-Pachon DA
    "Back to the future" projections for COVID-19 surges.
    PLoS One. 2024;19:e0296964.
    PubMed         Abstract available

  37. CANEDO MC, Lopes TIB, Rossato L, Nunes IB, et al
    Impact of COVID-19 pandemic in the Brazilian maternal mortality ratio: A comparative analysis of Neural Networks Autoregression, Holt-Winters exponential smoothing, and Autoregressive Integrated Moving Average models.
    PLoS One. 2024;19:e0296064.
    PubMed         Abstract available

  38. COLEMAN S, Slater MD, Wright P, Wright O, et al
    Pandemic lifeworlds: A segmentation analysis of public responsiveness to official communication about Covid-19 in England.
    PLoS One. 2024;19:e0296049.
    PubMed         Abstract available

  39. ATANASOV V, Barreto N, Franchi L, Whittle J, et al
    Evidence on COVID-19 Mortality and Disparities Using a Novel Measure, COVID excess mortality percentage: Evidence from Indiana, Wisconsin, and Illinois.
    PLoS One. 2024;19:e0295936.
    PubMed         Abstract available

  40. CHANG YY, Wei AC
    Transcriptome and machine learning analysis of the impact of COVID-19 on mitochondria and multiorgan damage.
    PLoS One. 2024;19:e0297664.
    PubMed         Abstract available


    Vaccine

  41. HUANG Y, Shi H, Forgacs D, Ross TM, et al
    Flu-COVID combo recombinant protein vaccines elicited protective immune responses against both influenza and SARS-CoV-2 viruses infection.
    Vaccine. 2024 Jan 30:S0264-410X(23)01543-8. doi: 10.1016/j.vaccine.2023.
    PubMed         Abstract available


    Virology

  42. YUAN F, Yang L, Hsiao SH, Herndon NL, et al
    A neonatal piglet model reveals interactions between nasal microbiota and influenza A virus pathogenesis.
    Virology. 2024;592:109996.
    PubMed         Abstract available

  43. FANG K, Song W, Zhang Y, Zheng Y, et al
    Comparative analysis and prediction of avian influenza in Shangrao city, China from 2016 to 2022.
    Virology. 2024;592:109995.
    PubMed         Abstract available

  44. HUONG TN, Lee ZQ, Lai SK, Lee HY, et al
    Evidence that an interaction between the respiratory syncytial virus F and G proteins at the distal ends of virus filaments mediates efficient multiple cycle infection.
    Virology. 2024;591:109985.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Influenza is free of charge.